Bharadwaj P, Banerji A, Datta R, Singh H, Ghosh A K, Keshavamurthy G
Senior Advisor (Medicine & Cardiology), MH (CTC), Pune.
Senior Advisor (Medicine & Cardiology), 166 MH, C/O 56 APO.
Med J Armed Forces India. 2008 Apr;64(2):131-5. doi: 10.1016/S0377-1237(08)80055-X. Epub 2011 Jul 21.
The Amplatzer perimembranous ventricular septal occluder is an innovative device for percutaneous closure of perimembranous ventricular septal defects (PMVSD). In appropriately selected cases this procedure is safe and effective.
Fourteen patients with the mean age 10.53 years (range 18 months to 55 years) and mean body weight 20.64 kg (range 6 to 52 kg) underwent PMVSD closure.
The PMVSD mean diameter was 5.28 mm (range from 4 to 9 mm). Implantation was successful in 92% of the cases and all patients had complete occlusion of the shunt within three months.
Device orientation was excellent in all cases. Device-related aortic insufficiency, tricuspid insufficiency or left ventricular dysfunction was not observed. One patient had embolisation of the device and another had complete heart block which required a permanent pacemaker implantation. The excellent short term results need to be confirmed over long-term follow-up.
Amplatzer膜周部室间隔封堵器是用于经皮闭合膜周部室间隔缺损(PMVSD)的一种创新装置。在适当选择的病例中,该手术安全有效。
14例患者接受了PMVSD封堵术,平均年龄10.53岁(范围18个月至55岁),平均体重20.64千克(范围6至52千克)。
PMVSD平均直径为5.28毫米(范围4至9毫米)。92%的病例植入成功,所有患者在三个月内分流完全闭塞。
所有病例中装置定位均良好。未观察到与装置相关的主动脉瓣关闭不全、三尖瓣关闭不全或左心室功能障碍。1例患者出现装置栓塞,另1例发生完全性心脏传导阻滞,需要植入永久性起搏器。优异的短期结果需要通过长期随访来证实。